Yanqing Gong Selected Research

Yanqing Gong Research Topics

Disease

58	Neoplasms (Cancer) 04/2024 - 05/2005
22	Renal Cell Carcinoma (Grawitz Tumor) 04/2024 - 06/2013
17	Urinary Bladder Neoplasms (Bladder Cancer) 07/2023 - 01/2015
14	Carcinoma (Carcinomatosis) 07/2023 - 08/2015
13	Neoplasm Metastasis (Metastasis) 07/2023 - 09/2015
12	Prostatic Neoplasms (Prostate Cancer) 02/2023 - 12/2012
9	Carcinogenesis 03/2023 - 12/2012
8	Glioblastoma (Glioblastoma Multiforme) 03/2024 - 05/2014
4	Hypoxia (Hypoxemia) 01/2024 - 05/2005
3	Kidney Neoplasms (Kidney Cancer) 01/2021 - 01/2020
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018 - 03/2016
2	Disease Progression 01/2024 - 01/2022
2	von Hippel-Lindau Disease (von Hippel Lindau Disease) 11/2023 - 01/2019
2	Adenocarcinoma 01/2021 - 06/2015
2	Ischemia 01/2020 - 01/2012
2	Urologic Neoplasms (Urological Cancer) 08/2018 - 01/2018
2	Myocardial Infarction 07/2014 - 01/2012
2	Inflammation (Inflammations) 05/2014 - 01/2009
2	Cardiovascular Diseases (Cardiovascular Disease) 05/2014 - 01/2012
1	Communicable Diseases (Infectious Diseases) 01/2024
1	Stomach Neoplasms (Stomach Cancer) 03/2023
1	Hepatocellular Carcinoma (Hepatoma) 03/2023
1	Colorectal Neoplasms (Colorectal Cancer) 03/2023
1	Fanconi Anemia (Fanconi's Anemia) 03/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	Microsatellite Instability 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Chromosomal Instability (Chromosome Stability) 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Radiation Injuries (Radiation Sickness) 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Cytokine Release Syndrome 12/2021
1	COVID-19 01/2021

Drug/Important Bio-Agent (IBA)

20	Biomarkers (Surrogate Marker)IBA 11/2023 - 08/2015
16	Long Noncoding RNAIBA 07/2023 - 07/2017
13	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2005
9	RNA (Ribonucleic Acid)IBA 03/2023 - 11/2018
7	DNA (Deoxyribonucleic Acid)IBA 06/2023 - 06/2013
5	Messenger RNA (mRNA)IBA 11/2023 - 07/2017
5	MicroRNAs (MicroRNA)IBA 03/2022 - 08/2018
4	Chimeric Antigen ReceptorsIBA 03/2024 - 01/2021
4	Cell-Free Nucleic AcidsIBA 01/2021 - 01/2020
4	PlasminogenIBA 01/2020 - 01/2009
3	Immune Checkpoint InhibitorsIBA 01/2023 - 11/2020
3	N-methyladenosineIBA 01/2022 - 03/2021
2	LipidsIBA 04/2024 - 09/2022
2	OsteopontinIBA 03/2024 - 05/2019
2	Competitive Endogenous RNAIBA 07/2023 - 11/2018
2	Prostate-Specific Antigen (Semenogelase)IBA 02/2023 - 01/2023
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 01/2021
2	Therapeutic UsesIBA 01/2021 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2018
2	LigandsIBA 01/2021 - 12/2012
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2020 - 11/2018
2	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 01/2016
2	Apolipoproteins AIBA 05/2014 - 01/2009
2	Oxygen (Dioxygen)IBA 05/2014 - 05/2005
1	CholesterolIBA 04/2024
1	Cholesterol Esters (Cholesteryl Esters)IBA 04/2024
1	cabotegravirIBA 01/2024
1	Genetic Markers (Genetic Marker)IBA 07/2023
1	TNF Receptor-Associated Factor 2 (TRAF2)IBA 07/2023
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2023
1	toosendaninIBA 01/2023
1	Phosphoglycerate Dehydrogenase (Dehydrogenase, Phosphoglycerate)IBA 01/2023
1	Serine (L-Serine)FDA Link 01/2023
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2022
1	Ubiquitin-Conjugating EnzymesIBA 03/2022
1	Cadherins (E-Cadherin)IBA 01/2022
1	ClaudinsIBA 01/2022
1	Dichlorodiphenyldichloroethane (DDD)IBA 01/2022
1	Ion Channels (Ion Channel)IBA 01/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	Adenosine Triphosphatases (ATPase)IBA 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	Small Cytoplasmic RNAIBA 01/2022
1	Sirolimus (Rapamycin)FDA Link 01/2022
1	claudin 10IBA 01/2022
1	atezolizumabIBA 01/2022
1	B7-H1 AntigenIBA 11/2021
1	Interleukin-13IBA 06/2021
1	Interleukin-10 (Interleukin 10)IBA 06/2021
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 02/2021
1	Peptides (Polypeptides)IBA 02/2021
1	Molecular Chaperones (Chaperone, Molecular)IBA 02/2021
1	Combined Antibody TherapeuticsIBA 01/2021
1	GP 4 (GP4)IBA 01/2021
1	LuciferasesIBA 01/2021
1	p21-Activated KinasesIBA 01/2021
1	enzalutamideIBA 01/2021
1	Enhancer RNAsIBA 01/2021

Therapy/Procedure

17	Therapeutics 01/2024 - 01/2012
11	Immunotherapy 03/2024 - 01/2020
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2018
3	Castration 01/2021 - 12/2012
2	Prostatectomy (Retropubic Prostatectomy) 02/2023 - 01/2020
1	Radiotherapy 01/2022
1	Vasectomy (Vas Occlusion) 12/2021